In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
The ESC Prevention of CVD Programme

Could your patients benefit from better secondary prevention?
Find out more with the scientific and educational resources from this multi-disciplinary programme.

Read more

European Journal of Preventive Cardiology

Addressing Causes and Prevention of Cardiovascular Disease, Cardiovascular Rehabilitation and Exercise Physiology

 

The European Journal of Preventive Cardiology (EJPC), the official journal of the European Association of Preventive Cardiology, embraces all scientific, clinical and public health disciplines that address the causes and prevention of cardiovascular disease, as well as cardiovascular rehabilitation and exercise physiology.

Fast Facts

  • Editor-in-chief: Massimo Francesco Piepoli (IT)
  • Current volume: 28 (year 2021)
  • Issues per subscription: 18
  • Impact Factor 2019: 5.864

 

Editor in chief History

Name Start Date End date
Professors Hugo Saner & David A Wood 01/01/2003 31/12/2005
Professors Pantaleao Giannuzzi & David A Wood 01/01/2006 31/12/2007
Professors Pantaleao Giannuzzi & Diederick Grobbee 01/01/2008 31/12/2009 
Professor Diederick Grobbee 01/01/2010 31/12/2016
Professor Massimo Piepoli 01/01/2017  

 

Updates on latest articles

Updates on latest articles

 

Receive the table of contents in your mailbox.

Track topics and authors important to you and receive articles in your mailbox.

For Authors

Before being published, all manuscripts go through double-blind peer review by experienced international experts.


Most recent articles from the EJPC

22 Mar 2021
Editors’ presentation: focus on pharmacological interventions
Author(s):Halasz G, Piepoli M.
17 Jan 2021
Type-2 diabetes patients at high risk for cardiovascular events: time to challenge the ‘metformin-always first’ paradigm
Author(s):Aboyans V, Sattar N.
09 Feb 2021
Something has got to give: funding innovation in an era of rigid budgeting, and why physicians should care
Author(s):Barradas-Pires A, DiazNuila Alcazar M, Martínez-Rubio A, et al.
26 Dec 2020
An ounce of prevention is worth a pound of cure: drugs and devices to prevent sudden cardiac death in heart failure
Author(s):Seferović P, Polovina M.